Search - tctmd.com

Displaying 261 - 280 of 15660

Sort: Relevancy | Date

Presentation TCT 2016

Impact of Implant Technique on Scaffold Thrombosis: The MICAT Experience

Presenter: Stephen G. Ellis, Patrick W. Serruys, Serban Puricel

November 01, 2016

Presentation TCT 2016

Portico: Design Features, Special Attributes, and Clinical Trial Program

Presenter: Eberhard Grube, James B. Hermiller Jr., Raj Makkar

November 01, 2016

Presentation TCT 2016

Hybrid/Guide Extension Reverse CART

Presenter: Alfredo R. Galassi, Masahiko Ochiai, Paul Knaapen

November 01, 2016

Presentation TCT 2016

Dosing Considerations of Oral Anticoagulant Therapy in the ACS and PCI Patient: Optimizing Efficacy While Minimizing Bleeding

Presenter: David P. Faxon, C. Michael Gibson

November 01, 2016

Presentation TCT 2016

FFR in the setting of CABG and AS/AVR/TAVR

Presenter: Bernard De Bruyne, Allen Jeremias, Emanuele Barbato

November 01, 2016

Presentation TCT 2016

New Valves for the Native RV Outflow Tract

Presenter: John P. Cheatham, Matthew J. Gillespie, Ziyad M. Hijazi

November 01, 2016

Presentation TCT 2016

A Critical Review of Technique Across the Absorb Trials

Presenter: Stephen G. Ellis, Patrick W. Serruys

November 01, 2016

Presentation TCT 2016

The Potential for 3D Printing and Imaging for LAA Closure

Presenter: Samir R. Kapadia, Apostolos Tzikas, James K. Min

November 01, 2016

Presentation TCT 2016

PSP: A Synthesis of Technique Imperatives for Absorb Implantation

Presenter: Stephen G. Ellis, Patrick W. Serruys, David G. Rizik

November 01, 2016

Presentation TCT 2016

Industry Perspectives: Balancing Innovation and Robust Clinical Evidence Generation With Declining DES Use and Reimbursement

Presenter: Michael C. John, Gregg W. Stone, Jason R. Weidman

November 01, 2016

Presentation TCT 2016

General Overview and Highlights of the North American Consensus Document on Anticoagulation in the Atrial Fibrillation Patient With ACS or PCI

Presenter: David P. Faxon, C. Michael Gibson, Dominick J. Angiolillo

November 01, 2016

Presentation TCT 2016

Bare Metal and 1st Generation Drug-Eluting Stents: Devices, Indications, and Outcomes

Presenter: Dmitriy N. Feldman, Emmanouil S. Brilakis

November 01, 2016

Presentation TCT 2016

Sensible Medical for Preventing Heart Failure Rehospitalizations

Presenter: JoAnn Lindenfeld, Ileana L. Pina, Daniel R. Bensimhon

November 01, 2016

Presentation TCT 2016

Complications of Transcatheter PVR

Presenter: John P. Cheatham, Matthew J. Gillespie, Thomas K. Jones

November 01, 2016

Presentation TCT 2016

Non-Hyperemic Indices: Glossary and Clinical Outcome Data

Presenter: Bernard De Bruyne, Allen Jeremias

November 01, 2016

Presentation TCT 2016

Impella RVAD-Assisted Acute Pulmonary Embolism Therapy: Rationale and Case Presentation

Presenter: Ori Ben-Yehuda, Ehtisham Mahmud, William W. O'Neill

November 01, 2016

Presentation TCT 2016

Additional LAA Imaging Techniques (Beyond TEE and CT): ICE, Fusion Imaging, and More

Presenter: Samir R. Kapadia, Apostolos Tzikas, Carlos E. Ruiz

November 01, 2016

Presentation TCT 2016

Impact of Small Vessels on BVS Outcomes and the Role of Target Vessel Mismatch

Presenter: Stephen G. Ellis, Patrick W. Serruys

November 01, 2016

Presentation TCT 2016

Highlights (And my Interpretations) From: Polymer-free DES - LEADERS-free 2-year and RevElution

Presenter: Philip M. Urban, Stephen G. Worthley, Christian M. Spaulding

November 01, 2016

Presentation TCT 2016

Transcatheter PVR for Native Outflow Tracts: How Much Can We Do With the Currently Approved Valves (Including Hybrid)?

Presenter: John P. Cheatham, Matthew J. Gillespie, Evan Zahn

November 01, 2016

Advertisement

Impact of Implant Technique on Scaffold Thrombosis: The MICAT Experience

Portico: Design Features, Special Attributes, and Clinical Trial Program

Hybrid/Guide Extension Reverse CART

Dosing Considerations of Oral Anticoagulant Therapy in the ACS and PCI Patient: Optimizing Efficacy While Minimizing Bleeding

FFR in the setting of CABG and AS/AVR/TAVR

New Valves for the Native RV Outflow Tract

A Critical Review of Technique Across the Absorb Trials

The Potential for 3D Printing and Imaging for LAA Closure

PSP: A Synthesis of Technique Imperatives for Absorb Implantation

Industry Perspectives: Balancing Innovation and Robust Clinical Evidence Generation With Declining DES Use and Reimbursement

General Overview and Highlights of the North American Consensus Document on Anticoagulation in the Atrial Fibrillation Patient With ACS or PCI

Bare Metal and 1st Generation Drug-Eluting Stents: Devices, Indications, and Outcomes

Sensible Medical for Preventing Heart Failure Rehospitalizations

Complications of Transcatheter PVR

Non-Hyperemic Indices: Glossary and Clinical Outcome Data

Impella RVAD-Assisted Acute Pulmonary Embolism Therapy: Rationale and Case Presentation

Additional LAA Imaging Techniques (Beyond TEE and CT): ICE, Fusion Imaging, and More

Impact of Small Vessels on BVS Outcomes and the Role of Target Vessel Mismatch

Highlights (And my Interpretations) From: Polymer-free DES - LEADERS-free 2-year and RevElution

Transcatheter PVR for Native Outflow Tracts: How Much Can We Do With the Currently Approved Valves (Including Hybrid)?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content